Breaking News

How could Makary transform the FDA?

December 17, 2024
Marty Makary, President-elect Trump's pick to run the FDA
Photo illustration: Christine Kao/STAT; Photo courtesy : Johns Hopkins University

STAT+ | Truth-teller or reflexive contrarian: Which Marty Makary would run the FDA?

Makary is a long-time critic of the medical establishment who's now set to regulate food, drugs, and medical devices at the FDA.

By Lizzy Lawrence


STAT+ | FDA deputy commissioner Namandjé Bumpus to leave agency

Namandjé Bumpus oversaw the FDA's recent reorganization, including the creation of a more unified human foods center.

By Lizzy Lawrence


Taxi drivers are steering neuroscience toward better understanding Alzheimer's

BMJ study shows taxi drivers die at lower rates from Alzheimer's disease than other professions, boosts earlier research on active use of hippocampus.

By Anil Oza



Hyacinth Empinado/STAT

STAT+ | Who stood out as Best Biopharma CEO of 2024? 

STAT's Adam Feuerstein isn't crowning a winner this year but says there were plenty of impressive performances worth recognizing.

By Adam Feuerstein


STAT+ | Bipartisan task force sets health AI oversight priorities for the next Congress

Lack of uniform standards for medical records and algorithms is impeding widespread adoption of health AI, a Congressional task force said.

By Brittany Trang


New model enables simpler, cheaper estimate of heart failure risk

The new PREVENT risk calculator identified a substantial new group of adults who are at risk for heart failure, a new study finds.

By Elizabeth Cooney


Transplant surgeon Robert Montgomery examines the pig kidney in a NYU Langone Health operating room.
Joe Carrotta for NYU Langone Health"

Gene-edited pig kidney transplanted into a third person, moving xenotransplants closer to trials

Following the Nov. 25 surgery, Looney has not had to be on dialysis for the first time in more than eight years, the NYU Langone team said

By Megan Molteni


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments